Your Source for Cardiopulmonary Information

 

Program
Title
Time
Price
MA-0628M
Alzheimer's Disease: Advances in Diagnosis & Treatment
120 min
$289.00

Donald Royall, MD; Steven Inbody, MD; Rachelle Doody, MD, PhD; Jary Lesser, MD

Understanding problem behaviour and dementia, strategy for treating Alzheimer's, differential diagnosis, management of non-cognitive symptoms.
MB-0711M
Geriatrics Horizons: Alzheimer’s Disease
90 min.
$249.00

Lisa P. Gwyther, MSW; Pierre N. Tariot, MD; Cornelia Beck, PhD; Peter J. Whitehouse, MD, PhD

Awareness of what patients & families want from health professionals; behavioral intervention which can be used to decrease disruptive behaviors and functional performance; Learn the cardinal features of dementia which will permit early diagnosis.

MB-0601M
New Directions in the Management & Treatment of Headaches
60 min.
$209.00

Seymour Diamond, MD; Richard B. Lipton, MD; Robert S. Kunkel, MD, FACP; R. Michael Gallagher, DO, FACOFP

Familiarizes viewers with the diagnosis and treatment of migraine headaches. A thorough discussion of the newest advances in the treatment of migraine, as well as standard forms of therapy, are presented.

MB-0915M
Pharmacology of Neuropathic pain": Corticosteroids, Anesthetics, Anticonvulsants  
30 min
$189.00

Mark Boswell, MD

(No Description Available.)

MB-1129M
Management of ALS: Asymptomatic Lateral Sclerosis
90 min.
$249.00

Hiroshi Mitsumoto, MD; Deborah F. Gelinas, MD; Robert G. Miller, MD; Robert C. Griggs, MD; Daniel S. Newman, MD; Gabriel T. Tatarian, DO; Sharon Hulihan, ACSW

This program will cover topics including: overview of ALS care; clinical trials of potential treatments and experimental results-IGFI and Riluzole; identifying goals of therapy and future directions for drug trials - BDNF; respiratory function; financial impact of ALS; symptomatic management and signs and symptoms of ALS .

MC-0131M
New Directions in the Treatment of Headaches
90 min.
$249.00

Seymour Diamond, MD; Merle L. Diamond, MD,FACP; Jack A. Klapper, MD; Brian Mondell, MD

Indications and agents used in the abortive and prophylactic treatment of migraine, non-pharmacologic intervention; aspects of diagnosis and current options of episodic and chronic cluster headache, therapeutic complexities of cranial neuralgias; distinction between episodic and chronic tension-type headaches, selection of agents used in chronic tension-type headaches due to anxiety and depression; factors impacting on the differential diagnosis of headache presented in the emergency dept., and the indications for neuroradiologic testing .
MJ-0611M
Current concepts in the Treatment of MS   
90 min.
$249.00

(No Description Available.)
ML-0701M
Botulinum Toxin in the Treatment of Myofascial Pain & Headache    
90 min.
  $249.00

(No Description Available.)
MJ-03001
Current Concepts in the Diagnosis & Treatment of Multiple Sclerosis   
90 min.
$249.00

(No Description Available.).

MB-0302M
Advances in Treatment of Herpes Zoster
120 min.
$289.00

Karl Buetner, MD; Richard Whitley, MD; Robert Dworkin, MD; John F. Flahery, PharmD; John Wolf, MD

The Pain Benefit for Anti-Herpetic Therapy in the Elderly; Therapeutic Advances in H. Zoster; Pharmacokinetics and Differentiation of Anti-Viral Therapy; Herpes Zoster: Pain Analysis.

MD-0423E
Alzheimer’s Disease and Dementia
60 min.
$209.00

Robert G. Nixon, BA, EMT-P; Jerry Douglas, MD; Ramona Stanfill, RN

This program will feature experts giving presentations on how to understand Alzheimer's disease and its effects. This program is designed to educate emergency medical professionals and nurses on the care of the patient with Alzheimer's disease, as well as dementia. This program will increase the viewer's awareness of Alzheimer's signs and symptoms, differentiate dementia from senility and focus on how to care for the patient with Alzheimer's disease.

MD-0722P
Advances in Managing Alzheimer's Disease
60 min.
$209.00

Kevin M. Furmaga, PharmD; Michael Koronkowski, PharmD; Vinod Kumar, MD, MRC

Topics include: Pathophysiology and Non-Cognitive Symptoms of Alzheimer's Disease; Cognitive Symptoms of Alzheimer's Disease; Future Directions in Drug Therapy for Alzheimer's Disease.


This healthcare portal website has been created as a source of objective and credible health and medical information for healthcare professionals and consumers and does not endorse any specific product, service or organization. MEDIVISION does not warrant the accuracy of this information, and it is intended as a supplement to, and NOT a substitute for, the knowledge, skill, and judgment of healthcare professionals. If you have questions about health care, please consult a physician or other health care professional.
COPYRIGHT © MEDIVISION, 2011